secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABEONA THERAPEUTICS INC. (ABEO)
CIK:        0000318306
Form:       8-K
Filed at:   2024-04-24T23:59:59+00:00
Accession:  0001493152-24-015792
Event type: other
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Abeona shareholders approve equity plan increase to 3.2M shares; re-elect two directors
--------------------------------------------------------------------------------

- A&R 2023 Equity Incentive Plan approved, increasing shares reserved from 1.7M to 3.2M (1.5M new shares).
- Leila Alland and Vishwas Seshadri re-elected as Class 2 directors with overwhelming support.
- Advisory vote on named executive officer compensation approved: 9,529,727 for, 402,844 against.
- Ratification of Deloitte & Touche as independent auditor for FY2024 approved: 14,720,159 for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318306/000149315224015792/0001493152-24-015792-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318306/000149315224015792/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-015792

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer